ipsogen PML-RARA bcr2 Kit

To ensure highest sensitivity, the ipsogen PML-RARA bcr2 kit has been optimized to detect PML-RARA bcr2 and ABL transcripts and uses prediluted plasmid standards and primers and probe mixes (see figuresAccurate detection of PML-RARA bcr2 fusion gene plasmid standards and Reliable detection of ABL plasmid standards).

The ipsogen PML-RARA bcr2 Kit is a ready-to-use kit for the quantification of PML-RARA bcr2 fusion transcripts using real-time PCR. The kit is based on the amplification and detection of specific PML-RARA bcr2 transcripts, relative to ABL control gene expression, in total RNA (see figures PML-RARA bcr2 gene transcript and ABL control gene transcript). The kit provides high levels of specificity, sensitivity, and reproducibility. Each ipsogen PML-RARA bcr2 Kit provides 5 standard dilutions for PML-RARA bcr2 fusion gene and 3 standard dilutions for ABL. Use of the standards enables accurate quantification of transcripts. Standardization and validation of the quantification method has been established by Europe Against Cancer (EAC) and the ipsogen PML-RARA bcr2 Kit is based on this technique.

The first step is reverse transcription of total RNA in a sample into cDNA. The second step is the amplification of cDNA by real-time PCR. Using the ipsogen PML-RARA bcr2 Kit allows detection and quantification of PML-RARA bcr2 and ABL transcripts. Simply start the reaction using the optimized protocols described in the kit handbook.

The ipsogen PML-RARA bcr2 Kit enable sensitive and reliable detection and quantification of PML-RARA bcr2 transcripts, relative to ABL control gene expression, for research use only.